Highlights
NASDAQ: MNLO       Menlo Therapeutics Inc
Last Price Today's Change   Day's Range   Trading Volume
4.31   -0.37 (7.91%)  4.30 - 4.70  51,621

Overview

 
Avg Volume (4 weeks):88,045
4 Weeks Range:4.30 - 5.80
4 Weeks Price Volatility (%):
0.67%
52 Weeks Range:2.69 - 9.031
52 Weeks Price Volatility (%):
25.55%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Menlo Therapeutics Inc is a US-based late-stage biopharmaceutical company which focuses on the development and commercialization of Serlopitant for the treatment of pruritus associated with dermatologic conditions such as atopic dermatitis, psoriasis, and prurigo nodularis. The pipeline product of the company includes Prurigo Nodularis, Prurigo Dermatitis, Psoriasis and Refractory Chronic Cough.

  Be the first to like this.
 


 

3028  2510  419  3020 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 FCEL 0.888+0.078 
 CHK 0.699-0.003 
 AMD 38.365+0.845 
 CSCO 44.795-3.665 
 AABA 19.630.00 
 CPE 4.245-0.215 
 SNNA 0.302+0.142 
 NIO 1.74-0.16 
 NOK 3.35-0.12 
 AMRN 21.490.00 
Partners & Brokers